The Challenge

The manufacturer had built its IBM software estate through two decades of direct procurement and legacy M&A activity. The core stack—DB2 Enterprise Edition, IBM MQ (formerly WebSphere MQ), WebSphere Application Server, and IBM SPSS—was distributed across multiple business units, geographies, and data centers. The Vice President of IT described the situation candidly: "We knew we had IBM software everywhere, but we didn't know what versions, how many instances, or where they all were. We'd inherited licenses from acquisitions in 2008, 2014, and 2019, and the contract management process was fragmented across procurement teams."

When IBM sent the pre-audit questionnaire—a standard audit trigger for mid-market manufacturers—the manufacturer was unprepared. The questionnaire requested comprehensive proof of entitlement for all IBM software deployed across the enterprise, including complete ILMT scan reports, hardware inventory documentation, virtualisation cluster mappings, and proof of license acquisition for every product and version.

The IT team conducted an initial self-audit and discovered critical gaps. ILMT had been deployed inconsistently across the 47 production servers. Several legacy DB2 instances were running on full-capacity licensing despite being deployed on virtualised infrastructure where sub-capacity licensing was eligible. WebSphere Application Server installations were oversized, with PVU allocations that exceeded actual workload requirements. SPSS licenses had been procured across three different business units without centralisation or rationalisation. Most critically, no comprehensive entitlement map existed—procurement records were scattered across multiple departments, some predating the manufacturer's ERP system migration.

The manufacturer engaged Redress after receiving IBM's preliminary audit findings. IBM's initial position calculated a total licensing obligation of $7.3M in annual run-rate costs, with an immediate true-up demand of $2.2M for the prior 18 months of alleged non-compliance. This created an immediate exposure of $4.2M when accounting for the audit settlement framework and potential penalties for ILMT non-deployment.

The Approach

Redress deployed a three-workstream strategy: estate discovery and rationalisation, ILMT deployment and compliance, and ELA negotiation.

Workstream 1: Comprehensive Licensing Estate Discovery

Within the first week, Redress conducted a complete audit of the manufacturer's IBM licensing landscape. This involved reconciling procurement records across all 47 production servers, virtualisation cluster documentation, legacy acquisition contracts, and historical software inventory data. The discovery process identified 34 distinct IBM products or modules in the estate, spanning database, middleware, analytics, and development tools.

For DB2 specifically, the audit revealed that 12 of 18 instances qualified for sub-capacity licensing under the virtualisation topology. The manufacturer was allocated 2,240 PVUs under full-capacity licensing when the actual virtualised allocation justified only 980 PVUs—a recalculation that alone delivered $1.6M in annual savings. The manufacturer's WebSphere Application Server deployments were similarly oversized. Thirteen instances were licensed at premium PVU allocations when analysis of actual workload distribution and redundancy requirements justified a 35% reduction in PVU allocation across the cluster—a rationalisation that delivered $900K in annual savings.

SPSS licenses presented a different problem. The manufacturer had purchased SPSS under four separate procurement events over 12 years. By consolidating licences and re-evaluating deployment scope, Redress identified 18 unused named-user licenses and six perpetual seats that had been over-allocated. License consolidation and cloud-based alternative analysis revealed that the manufacturer could migrate 40% of SPSS workload to lower-cost cloud analytics platforms, delivering $600K in annual savings.

Workstream 2: ILMT Deployment and Compliance Remediation

The manufacturer's inability to produce comprehensive ILMT reports was a critical audit vulnerability. Without ILMT, IBM auditors default to full-capacity licensing for every server with IBM software deployed—a position that would have converted potential compliance issues into catastrophic financial exposure.

Redress designed and executed an accelerated ILMT deployment across all 47 production servers within 6 weeks. This involved installing ILMT agents on every host, configuring scan schedules aligned with IBM's audit requirements (weekly minimum), validating agent health dashboards, and generating baseline compliance reports.

Simultaneously, Redress worked with the manufacturer's infrastructure team to document virtualisation topology, hyper-visor configurations, cluster boundaries, and processor allocation methods. This documentation became the foundation for sub-capacity licensing claims. The complete audit trail—ILMT reports, virtualisation diagrams, cluster configuration documents, and entitlement records—provided IBM auditors with comprehensive proof of the manufacturer's compliance posture and sub-capacity eligibility.

Facing an IBM audit or pre-audit questionnaire?

Download the IBM Audit Defence Kit—a complete playbook for closing audit exposure and negotiating ELA terms.
Get the Audit Defence Kit →

Workstream 3: ELA Negotiation and Audit Settlement

Armed with comprehensive audit data, sub-capacity documentation, and a clear entitlement map, Redress engaged IBM's Licensing, Compliance, and Contracts team to negotiate audit settlement and a forward-looking ELA.

IBM's initial audit settlement position assumed full-capacity licensing at pre-audit rates. The manufacturer's documented sub-capacity allocation, supported by ILMT reports and virtualisation topology, justified a significant reduction in the alleged compliance gap. The audit settlement negotiation focused on three leverage points: (1) the manufacturer's good-faith ILMT deployment demonstrating commitment to compliance going forward, (2) sub-capacity eligibility documentation that was irrefutable under IBM's own audit methodology, and (3) the manufacturer's willingness to consolidate its fragmented purchasing into a unified three-year ELA covering all IBM products.

Redress structured the settlement to close IBM's $4.2M audit exposure for zero additional payment. This was achieved through a combination of: $1.6M reduction in DB2 obligations through sub-capacity recalculation, $900K reduction in WebSphere licensing through PVU rationalisation, $600K reduction in SPSS obligations through consolidation and cloud migration, and $100K reduction in other miscellaneous licensing gaps through entitlement mapping and true-up reconciliation.

The forward-looking ELA was negotiated at $3.1M annual run-rate costs—a 17% reduction versus IBM's audit settlement offer of $3.75M annually. The ELA term was structured at three years with fixed pricing in year one, 3% annual escalation thereafter, explicit sub-capacity recognition, ILMT compliance requirements, and defined governance for software deployment changes.

The Outcome

The manufacturer transformed its IBM licensing posture from audit vulnerability to strategic advantage in six weeks. The complete outcome:

  • $4.2M Audit Exposure Closed: IBM's initial $4.2M compliance demand (covering 18 months of alleged over-capacity and SPSS over-allocation) was fully resolved without additional payment. Redress's documentation of sub-capacity eligibility and entitlement mapping eliminated IBM's negotiating position.
  • $3.1M Annual Savings Realised: The manufacturer locked in $3.1M in annual savings through a combination of sub-capacity recalculation, PVU optimisation, SPSS rationalisation, and cloud migration. These savings are perpetual and compound over the three-year ELA term to $9.3M in total cost avoidance.
  • 17% Below IBM's Offer: The negotiated ELA run-rate of $3.1M represented a 17% discount versus IBM's audit settlement offer of $3.75M annually. This represented an additional $1.95M savings opportunity that would have been lost without independent negotiation.
  • Compliance Infrastructure Deployed: The manufacturer's 47 production servers now operate under comprehensive ILMT monitoring, meeting IBM's audit requirements and eliminating the risk of future full-capacity licensing defaults.
  • Vendor Relationship Reset: The ELA established explicit product entitlement, deployment governance, and escalation procedures that transformed the relationship from adversarial (audit-driven) to collaborative (strategic partnership).

Six months after engagement completion, the manufacturer had deployed a new instance of WebSphere Application Server for a critical manufacturing operations initiative. Because the ELA explicitly covered WebSphere deployment and ILMT scanning was operational, the deployment proceeded with complete licensing clarity and audit-ready documentation from day one.

Key Takeaways

ILMT Deployment is Non-Negotiable: IBM's audit methodology automatically defaults to full-capacity licensing for servers without comprehensive ILMT reporting. The manufacturer's six-week ILMT deployment eliminated the audit risk that would have inflated the compliance claim by 3-5x. Without ILMT, the manufacturer would have faced a multi-million dollar exposure that was entirely avoidable.

Sub-Capacity Requires Documentation: Sub-capacity licensing eligibility exists in IBM contracts, but realising the savings requires proof. Comprehensive virtualisation topology documentation, cluster boundary maps, and ILMT reports form the evidentiary foundation for sub-capacity claims. The manufacturer's $1.6M DB2 savings would not have been realised without this documentation.

Fragmented Licensing Creates Exposure: The manufacturer's scattered procurement records and multiple SPSS purchasing decisions created duplicate licenses and over-allocation. Consolidation delivered both immediate compliance clarity and ongoing cost savings. Large enterprises with decentralised procurement benefit significantly from centralised licensing governance.

Audit Exposure is a Negotiation Trigger, Not a Verdict: IBM's initial $4.2M audit position was derived from assumptions about full-capacity licensing and default compliance scenarios. With proper documentation and expert negotiation, audit exposure can be eliminated entirely. The manufacturer negotiated from a position of strength once the compliance facts were documented.

ELA Consolidation Delivers Leverage: The manufacturer's ability to consolidate fragmented IBM purchases into a single three-year agreement created negotiation leverage that IBM's account team valued. The 17% discount below audit settlement offer would not have been achievable in standalone product negotiations.